ESC 365 - SGLT2 blockers in AF: the best AAD ever?

EHRA Premium Access

SGLT2 blockers in AF: the best AAD ever?

Session: Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Topic: Heart Failure in Atrial Fibrillation

Speaker: Professor F. Ruschitzka (Zurich, CH)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)

105 presentations

17 followers

4 more presentations in this session

AF in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speaker: Professor R. De Boer (Rotterdam, NL)

Insights from the Castle AF: why was it positive?

Speaker: Professor N. Marrouche (New Orleans, US)

The future of AF ablation in heart failure.

Speaker: Professor D. Gupta (Liverpool, GB)

Atrial Fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference? - discussion.

Access the full session

Atrial fibrillation (AF) in HFrEF, HFmrEF and HFpEF: does it make any difference?

Speakers: Professor F. Ruschitzka, Professor R. De Boer, Professor N. Marrouche, Professor D. Gupta

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources